Prot #ALT-002-SRE-01: A Phase I/II Dose Escalation Study of AP-002 In Patients with Advanced or Recurrent Solid Tumors

  • Shah, Ami N (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date12/9/19 → 12/9/22

Funding

  • Altum Pharmaceuticals Inc. ((OE) Prot #ALT-002-SRE-01)